Recent Posts
- CV6 to Present Details of Ongoing Phase 1a Clinical Trial at 2024 ASCO Annual Meeting
- CV6 Therapeutics to Attend JP Morgan Week
- CV6 Receives MHRA Approval for Novel Cancer Therapy Phase 1a Clinical Trial
- CV6 CEO Co-authors Study on Cancer Care in Ireland
- CV6 CEO Presents at ‘Agreement 25: Cancer Knows no Borders’